BURLINGTON, ON, Nov. 5, 2012 /PRNewswire/ - EKO INTERNATIONAL
INC. (the "Company") -(EKNL- Pinksheets) is pleased to announce
that NeuroVasc Clinical Inc. reports initial sales of $186,000 for the month of October 2012. Sales included FREMS equipment,
NC-stat DPN Check devices and supplies.
Although a minor portion of October sales resulted from
attendance at the Canadian Federation of Podiatric Medicine
Conference in London, Ontario on
October 26th and
27th, 2012, the Company is optimistic that the interest
demonstrated in its products by health professionals will result in
increased monthly sales volumes for the balance of this
quarter.
This press release contains forward-looking statements that
reflect the Company's current expectation regarding future events.
Actual events could differ materially and substantially from those
projected herein and depend on a number of factors. Certain
statements in this release, and other written or oral statements
made by EKO International ("The Company") are "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934. You
should not place undue reliance on forward-looking statements since
they involve known and unknown risks, uncertainties and other
factors, which are, in some cases, beyond the Company's control and
which could, and likely will, materially affect actual results,
levels of activity, performance or achievements. The Company
assumes no obligation to publicly update or revise these
forward-looking statements for any reason, or to update the reasons
actual results could differ materially from those anticipated in
these forward-looking statements, even if new information becomes
available in the future. Important factors that could cause actual
results to differ materially from the company's expectations
include, but are not limited to, those factors that are disclosed
under the heading "Risk Factors" and elsewhere in documents filed
by the company from time to time with the United States Securities
and Exchange Commission and other regulatory authorities.
SOURCE EKO INTERNATIONAL CORP.